A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer; Japan Clinical Oncology Group (JCOG0403); Long Term Follow-up Results

Y Nagata,M Hiraoka,T Shibata,H Onishi,M Kokubo,K Karasawa,Y Shioyama,R Onimaru,E Kunieda,S Ishikura

doi:10.1016/j.ijrobp.2018.06.115

A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer; Japan Clinical Oncology Group (JCOG0403); Long Term Follow-up Results

Y Nagata, M Hiraoka + Show 8 more

https://doi.org/10.1016/j.ijrobp.2018.06.115

Copy DOI

Journal: International Journal of Radiation OncologyBiologyPhysics	Publication Date: Oct 20, 2018
Citations: 2

Affiliation: Japanese Red Cross Society Wakayama Medical Center, University of Yamanashi, Kobe City Medical Center General Hospital, Tokyo Metropolitan Komagome Hospital, SAGA Heavy Ion Medical Accelerator in Tosu, Hokkaido University, Tokai University, Nagoya City University

#T1N0M0 Non-Small Cell Lung Cancer #T1N0M0 Non-Small Cell Lung + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

8512Background: The purpose was to evaluate the safety and efficacy of stereotactic body radiation therapy (SBRT) in patients (pts) with both operable and inoperable T1N0M0 non-small cell lung canc...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: International Journal of Radiation OncologyBiologyPhysics

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.